Utility Menu

National Association of Pharmacy Regulatory Authorities


Main navigation

Committee Members

Dr. Thomas Bailey, M.D.
Langford, British Columbia

Appointed: September 2012 to September 2015
Reappointed: September 2015 to September 2018

Extended: September 2018 to November 2019


Sincerest Sympathies on Behalf of NAPRA: Dr. Thomas Bailey (1951-2019)


We at NAPRA are deeply saddened to hear of the sudden passing of our dear colleague and friend, Dr. Thomas Bailey.  He will be remembered for his kind nature, strong leadership, over 40 years’ experience as a dedicated physician, and his valuable contributions to drug safety and regulation.  Dr. Bailey served as chair of the National Drug Scheduling Advisory Committee (NDSAC) since June of 2016, and has been a long standing member with the committee since September 2012.  We join his family, friends, patients, and colleagues during this sad time, and extend our most heartfelt condolences.


Dr. Bailey is a family physician with over thirty years of practice experience in British Columbia. He also holds a dual academic appointment as a Clinical Associate Professor with the Faculty of Medicine at the University of British Columbia, and Affiliate Clinical Associate Professor with the Division of Medical Sciences at the University of Victoria (affiliated with the University of British Columbia). Dr. Bailey has a long-standing interest in drug safety and regulation. He sat as both a member and Chair of the Pharmacy and Therapeutics Committee for two hospitals that now form part of the Vancouver Island Health Authority. In addition, Dr. Bailey possesses wide clinical expertise and knowledge of issues regarding patient safety and primary care.


Dr. Murray Brown, B.Sc. (Pharm), Pharm.D.
Shanty Bay, Ontario

Appointed: January 2013 to January 2016
Reappointed: January 2016 to January 2019

Extended: January 2019 to January 2021

Dr. Brown worked as head of the pharmacy practice section of the University of Saskatchewan, College of Pharmacy before beginning a career of more than 27 years in regulatory affairs in the pharmaceutical industry. For much of this time, he worked specifically in the area of non-prescription medicines. He also worked as an independent consultant and served as the Executive Director of the Canadian Foundation for Pharmacy. Dr. Brown has previous experience working with the National Drug Scheduling Advisory Committee. He also served as past President of the Canadian Society of Industrial Pharmacists, Vice President of the Canadian Pharmaceutical Association and as a member of the editorial advisory panel for the Compendium of Pharmaceuticals and Specialties. Most recently, Dr. Brown worked as Vice President of Scientific Affairs for a major pharmaceutical company. He recently retired from the pharmaceutical industry and continues to maintain a practicing pharmacy licence in the province of Ontario.


Dr. Drena Dunford, B.Sc.Hons, B.Sc. (Pharm), Pharm.D.

Winnipeg, Manitoba


Appointed: January 2013 to January 2016

Reappointed: January 2016 to January 2019

Extended: January 2019 to January 2021


Ms. Dunford is an Instructor at the Faculty of Pharmacy of the University of Manitoba where she coordinates the Clinical Pharmacy I course, which primarily covers patient self-care conditions with a focus on over-the-counter medications. She is also a case writer and evaluator in a number of other courses, guest lecturer in the pharmacology course for the School of Dental Hygiene at the Faculty of Dentistry and was a previous Co-Chair of the Oral and Systemic Health Interprofessional Education Working Group. Ms. Dunford is a licensed pharmacist in the province of Manitoba and multiple recipient of the Manitoba Pharmaceutical Association Certificate of Achievement in Lifelong Learning in Pharmacy. After graduating from the University of Toronto Faculty of Pharmacy, Ms. Dunford worked in a variety of settings including community pharmacy and a primary care clinic on the Canadian Forces Base in Winnipeg where she was actively involved in accreditation and patient safety initiatives before beginning her career in education with the University of Manitoba.


Dr. Melanie Johnson, B.Sc. (Pharm), Pharm.D.

Vancouver, British Columbia

Appointed: August 2014 to August 2017

Reappointed: August 2017 to August 2020

Extended: February 2020 to February 2022 

Dr. Johnson is a Drug and Poison Information Pharmacist at the British Columbia Drug and Poison Information Centre and provides drug information to healthcare professionals and poison information to both healthcare professionals and members of the public. She also works at a private interdisciplinary pain management clinic where she assists with monitoring and adjustment of pain medications for patients with chronic pain. Dr. Johnson is certified in Poison Information, Asthma and Pain Education. She is a licensed pharmacist and has additional training in adult education and lectures at the University of British Columbia on the topics of asthma, COPD, drug hypersensitivity and pain medications. She has completed the Canadian Pharmacists Association ADAPT program and has also participated as an ADAPT moderator.


Dr. Deborah Kelly, B.Sc. (Pharm), ACPR, Pharm.D., FCSHP, AAHIVP

St. John’s, Newfoundland and Labrador


Appointed: February 2014 to February 2017
Reappointed: January 2017 to February 2020
Extended: February 2020 to February 2022 


Dr. Kelly is the Clinical Pharmacotherapy Specialist with the provincial HIV program under Eastern Health. She is an Associate Professor at the School of Pharmacy, Memorial University of Newfoundland (MUN) with a cross appointment to the Discipline of Medicine. She serves on a variety of different committees in the pharmacy community and is a past Chair of the Newfoundland and Labrador Pharmacy Board. Dr. Kelly has conducted and published research in the areas of inter-professional collaboration, pharmacist scope of practice and rational drug use. She has numerous publications and invited presentations to her name and is a reviewer for publications such as the Canadian Pharmacists Journal and the International Journal of Pharmacy Practice

Dr. Jason Kielly, B.Sc. (Pharm), Pharm.D. 
St. John’s, Newfoundland and Labrador

Appointed: October 2016 to October 2019
Reappointed: November 2019 to November 2022 


Dr. Kielly is an Assistant Professor at the School of Pharmacy, Memorial University, where he lectures on a broad range of therapeutic topics such as musculoskeletal disorders, cardiovascular disease, headache disorders, geriatric psychiatry and clinical toxicology. He is a Clinical Pharmacotherapy Specialist with the Rheumatic Health Program at Eastern Health. Dr. Kielly has served as the Newfoundland and Labrador representative on the Atlantic Common Drug Review (ACDR) Atlantic Expert Advisory Committee since May 2011. He is currently involved with a number of research projects that aim to assess the value of pharmacy practice activities in both collaborative practice and in community pharmacy settings. Most recently, Dr. Kielly was the co-principal investigator on a successful Canadian Institutes of Health Research (CIHR) grant that aims to assess the feasibility and acceptability of point-of-care testing for HIV by community pharmacists.

Judith McPhee, B.Sc. (Pharm)
Halifax, Nova Scotia

Appointed: February 2014 to February 2017
Reappointed: January 2017 to February 2020

Ms. McPhee, before retiring in January 2017, was the Executive Director for Pharmaceutical Services and Extended Health Benefits with the Nova Scotia Department of Health and Wellness. After graduating from Dalhousie University, Ms. McPhee worked in a variety of pharmacy practice settings, including community and industry. She spent the majority of her career in hospital pharmacy, gaining experience as a clinical pharmacist and as a pharmacy manager, before beginning a career in provincial government in 2004 with the Nova Scotia Department of Health and Wellness. Ms. McPhee served as Co-Chair of the Pan-Canadian Pricing Alliance and the Pan-Canadian Generic Value Price Initiative through the Council of the Federation Health Care Innovation Working Group and Vice-Chair of the Drug Policy Advisory Committee at the Canadian Agency for Drugs and Technologies in Health. 

Kendra Townsend, B.S.P., CDE
(Vice-Chair, June 2016)
Regina, Saskatchewan

Appointed: February 2014 to February 2017
Reappointed: January 2017 to February 2020

Ms. Townsend is currently with Prairie Vascular Research Network based out of the Regina General Hospital. She previously co-owned Townsend’s Drugs in Wynyard, Saskatchewan for 20 years with her husband, Dallas. An experienced and leading community pharmacist, she also worked part time at the Wynyard Community Health Centre as a primary health care team pharmacist. As a Certified Diabetes Educator, she coordinated the Wynyard Diabetes Education and Management Project, which included providing diabetes education and consultation outreach services to First Nation communities in the area. Ms. Townsend is an authorized prescriber with the minor ailments prescribing program in Saskatchewan and is certified in administering injectable products. She is dedicated to improving pharmacy practice and demonstrates this commitment through her participation in community pharmacy practice research, and by serving on various committees such as the Editorial Advisory Board of the Canadian Pharmacists Journal and the Board of Directors of the Pharmacy Examining Board of Canada.

Committee Observers:
Joan Sayer - Consumers’ Association of Canada
Dr. Shiva Ghimire - Natural and Non-prescription Health Products Directorate, Health Canada